vimarsana.com

Page 103 - பொது ஆரோக்கியம் அடித்தளம் ஆஃப் இந்தியா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

India giving COVID-19 vaccines to more people as cases rise | Taiwan News

2021/03/01 12:11 In this photo provided by Prime Minister of India Narendra Modi s twitter handle, Indian Prime Minister Narendra Modi is administered a COVID-19 vacci. In this photo provided by Prime Minister of India Narendra Modi s twitter handle, Indian Prime Minister Narendra Modi is administered a COVID-19 vaccine in New Delhi, India, Monday, March 1, 2021. India is expanding its COVID-19 vaccination drive beyond health care and front-line workers, offering the shots to older people and those with medical conditions that put them at risk. As of Monday, those eligible to be vaccinated include people over 60, as well as those over 45 who have ailments such as heart disease or diabetes that make them vulnerable to the coronavirus. (Prime Minister of India Narendra Modi s twitter handle via AP Photo)

India giving COVID-19 vaccines to more people as cases

India giving COVID-19 vaccines to more people as cases
accesswdun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from accesswdun.com Daily Mail and Mail on Sunday newspapers.

Rs 250 Still a High Cost , Say Public Health Experts on Vaccine Pricing

Comments The Union Government on Saturday, February 27, announced that its citizens above the age of 60 and those above 45 and living with comorbidities will be vaccinated starting March 1. India also became the first country in the world to provide COVID-19 vaccines at a cost at private hospitals. The price fixed is Rs 250 per dose, with the vaccine cost fixed at Rs 150, and Rs 100 is administering charge. At Rs 150, the cost of the vaccine is lower than the price the government is purchasing at from pharma companies. As per earlier reports, the government has purchased Covishield, manufactured in India by Serum Institute, at 210 per dose, and the India-made Covaxin, manufactured by Bharat Biotech, at Rs 295 per dose.

Coronavirus | Comorbidities list for vaccine eligibility seen as too narrow

Coronavirus | Comorbidities list for vaccine eligibility seen as too narrow Updated: Updated: Focus on severe ailments, combination of diseases excluding many: experts Share Article AAA India, as part of the second phase of vaccination, made people aged over 60 years and those above 45 years with comorbidities eligible to get a vaccine from March 1   | Photo Credit: PICHUMANI K Focus on severe ailments, combination of diseases excluding many: experts The Union Health Ministry’s list of 20 comorbidities that make people in the 45-59 year age group eligible for a COVID-19 vaccine is seen by some medical professionals as too narrow. “The list of comorbidities provided by the Health Ministry is overly restrictive and complicated. Many conditions, including obesity, have been left out,” said Dr. Gagandeep Kang, Professor of Microbiology at CMC Vellore.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.